Page last updated: 2024-11-02

pargyline and Bulimia

pargyline has been researched along with Bulimia in 1 studies

Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.

Bulimia: Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as ox hunger.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Keck, PE1
Vuckovic, A1
Pope, HG1
Nierenberg, AA1
Gribble, GW1
White, K1

Trials

1 trial available for pargyline and Bulimia

ArticleYear
Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment.
    Journal of clinical psychopharmacology, 1989, Volume: 9, Issue:3

    Topics: Agoraphobia; Blood Pressure; Bulimia; Depressive Disorder; Humans; Mental Disorders; Monoamine Oxida

1989